PubRank

Stephan Ladisch

Author PubWeight™ 51.73‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007 16.96
2 Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002 3.54
3 Construction of long DNA molecules using long PCR-based fusion of several fragments simultaneously. Nucleic Acids Res 2004 3.30
4 Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. Blood 2007 2.61
5 Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood 2013 2.46
6 Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood 2011 2.35
7 Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005 1.64
8 Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis. Br J Haematol 2007 1.27
9 2'-Chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the Histiocyte Society. Pediatr Blood Cancer 2009 1.12
10 Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization. J Biol Chem 2004 1.04
11 Membrane ganglioside enrichment lowers the threshold for vascular endothelial cell angiogenic signaling. Cancer Res 2006 0.99
12 Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts. Glycobiology 2008 0.96
13 Alteration of ganglioside synthesis by GM3 synthase knockout in murine embryonic fibroblasts. Biochim Biophys Acta 2007 0.92
14 Reactivations in multisystem Langerhans cell histiocytosis: data of the international LCH registry. J Pediatr 2008 0.90
15 Biological stratification of human neuroblastoma by complex "B" pathway ganglioside expression. Cancer Res 2003 0.88
16 Inhibition of TLR activation and up-regulation of IL-1R-associated kinase-M expression by exogenous gangliosides. J Immunol 2008 0.87
17 Inhibition of melanoma tumor growth by a novel inhibitor of glucosylceramide synthase. Cancer Res 2003 0.86
18 Modulation of growth factor signaling by gangliosides: positive or negative? Methods Enzymol 2006 0.84
19 Mechanisms of ganglioside inhibition of APC function. J Immunol 2003 0.83
20 Tumor gangliosides accelerate murine tumor angiogenesis. Angiogenesis 2013 0.82
21 Ganglioside GD1a impedes lipopolysaccharide-induced maturation of human dendritic cells. Cell Immunol 2002 0.82
22 Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation. Blood 2005 0.81
23 Transfection of glucosylceramide synthase antisense inhibits mouse melanoma formation. Glycobiology 2002 0.81
24 N-butyldeoxynojirimycin inhibits murine melanoma cell ganglioside metabolism and delays tumor onset. Cancer Lett 2003 0.81
25 Modulation of CD4 Th cell differentiation by ganglioside GD1a in vitro. J Immunol 2005 0.81
26 Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood. Br J Haematol 2014 0.81
27 Low complex ganglioside expression characterizes human neuroblastoma cell lines. Cancer Lett 2005 0.80
28 Ganglioside inhibition of CD8+ T cell cytotoxicity: interference with lytic granule trafficking and exocytosis. J Immunol 2012 0.79
29 Induction of GM1a/GD1b synthase triggers complex ganglioside expression and alters neuroblastoma cell behavior; a new tumor cell model of ganglioside function. Glycoconj J 2011 0.78
30 Ganglioside-exposed dendritic cells inhibit T-cell effector function by promoting regulatory cell activity. Immunology 2010 0.77
31 Tumor progression and metastasis from genetic to microenvironmental determinants: a workshop of the tumor progression and metastasis NIH study section in honor of Dr. Martin L. Padarathsingh, May 31, 2006, Georgetown, Washington, DC. Cancer Biol Ther 2006 0.76
32 Immunosuppressive treatment for chemotherapy-resistant multisystem Langerhans cell histiocytosis. Med Pediatr Oncol 2003 0.75